Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep:216:107333.
doi: 10.1016/j.rmed.2023.107333. Epub 2023 Jun 17.

Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension

Jasmine Vakhshoorzadeh  1 , Justin K Lui  2 , Ruchika A Sangani  2 , Marcin A Trojanowski  3 , Andreea M Bujor  3 , Michael P LaValley  4 , Elizabeth S Klings  2
Affiliations

Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension

Jasmine Vakhshoorzadeh et al. Respir Med. 2023 Sep.
No abstract available

Keywords: Chronic obstructive pulmonary disease; Forced vital capacity; Pulmonary arterial hypertension; Pulmonary function testing; Scleroderma.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Justin K. Lui reports financial support was provided by United Therapeutics Corporation and the National Scleroderma Foundation. Justin K. Lui reports financial support was provided by National Heart Lung and Blood Institute. Michael P. LaValley reports financial support was provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Andreea M. Bujor reports financial support was provided by National Heart Lung and Blood Institute. Elizabeth S. Klings reports financial support was provided by National Heart Lung and Blood Institute. Elizabeth S. Klings reports financial support was provided by National Center for Advancing Translational Sciences. Elizabeth S. Klings reports financial support was provided by Health Resources and Services Administration. Elizabeth S. Klings reports financial support was provided by Bayer Corporation. Elizabeth S. Klings reports financial support was provided by Forma Therapeutics Inc. Elizabeth S. Klings reports financial support was provided by Novartis. Elizabeth S. Klings reports financial support was provided by United Therapeutics Corporation. Elizabeth S. Klings reports a relationship with Bluebird Bio Inc that includes: board membership and consulting or advisory. Elizabeth S. Klings reports a relationship with Vertex that includes: board membership and consulting or advisory. Elizabeth S. Klings reports a relationship with Forma Therapeutics Inc that includes: board membership and consulting or advisory. Elizabeth S. Klings reports a relationship with CSL Behring LLC that includes: board membership and consulting or advisory.

Similar articles

See all similar articles

References

    1. Steen VD, Medsger TA, Changes in causes of death in systemic sclerosis, 1972–2002, Ann. Rheum. Dis. 66 (7) (2007. Feb 2) 940–944. PMCID: PMC1955114. - PMC - PubMed
    1. Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J, Ahmad K, Bertoletti L, Camara B, Gomez E, Launay D, Montani D, Mornex JF, Prévot G, Sanchez O, Schott AM, Subtil F, Traclet J, Turquier S, Zeghmar S, Habib G, Reynaud-Gaubert M, Humbert M, Cottin V, Hemodynamic response to treatment and outcomes in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis: data from a study identifying prognostic factors in pulmonary hypertension associated with interstitial lung disease, Arthritis Rheumatol Hoboken NJ 73 (2) (2021. Feb) 295–304. PMID: 32892515. - PubMed
    1. Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM, Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies, Arthritis Rheum. 63 (8) (2011. Aug) 2456–2464. PMID: 21538327. - PubMed
    1. Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE, Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease, Arthritis Rheum. 60 (2) (2009. Feb) 569–577. PMID: 19180517. - PubMed
    1. Sangani RA, Lui JK, Gillmeyer KR, Trojanowski MA, Bujor AM, LaValley MP, Klings ES, Clinical Characteristics and outcomes in pulmonary manifestations of systemic sclerosis: contribution from pulmonary hypertension and interstitial lung disease severity, Pulm. Circ. (2022. Oct 1) 12(4):e12117 PMID 36238967. - PMC - PubMed

Publication types

MeSH terms